MedTrace Logo

Patient Journey in Advanced Gynecologic Cancers

NCT07015593 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 780

Last updated 2025-06-11

No results posted yet for this study

Summary

This is a mixed-methods survey study including a 2-phased sequential-explanatory design. This study is to understand the patient journey in conventional therapy for newly diagnosed stage III or IV CC or EC in China, including ①patients' treatment decision making factors and treatment experiences and ② patients' unmet needs during post-treatment surveillance.

Conditions

  • Genital Neoplasms, Female
  • Uterine Cervical Neoplasms
  • Endometrial Carcinoma

Interventions

OTHER

interview

30 for Qualitative interview and 750 for quantitative survey

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Gang Chen, PhD · Tongji Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-07-01
Completion
2026-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07015593 on ClinicalTrials.gov